Literature DB >> 18638445

Method to eliminate linear DNA from mixture containing nicked circular, supercoiled, and linear plasmid DNA.

Pichumani Balagurumoorthy1, S James Adelstein, Amin I Kassis.   

Abstract

Preparations of circular plasmid DNA in either supercoiled or nicked circular form often are contaminated with undesired linear DNA fragments arising from shearing/degradation of chromosomal DNA or linearization of plasmid DNA itself. We report a simple enzymatic method, using a combination of lambda exonuclease and RecJ(f), for the selective removal of linear DNA from such mixtures. lambda exonuclease digests one strand of linear duplex DNA in the 5' to 3' direction, whereas RecJ(f), a single-strand-specific exonuclease, digests the remaining complementary single strand into mononucleotides. This combination of exonucleases can remove linear DNA from a mixture of linear and supercoiled DNA, leaving the supercoiled form intact. Furthermore, the inability of lambda exonuclease to initiate digestion at nicks or gaps enables the removal of undesired linear DNA when nicked circular DNA has been enzymatically prepared from supercoiled DNA. This method can be useful in the preparation of homogeneous circular plasmid DNA required for therapeutic applications and biophysical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638445      PMCID: PMC2832929          DOI: 10.1016/j.ab.2008.06.037

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Separation of different physical forms of plasmid DNA using a combination of low electric field strength and flow in porous media: effect of different field gradients and porosity of the media.

Authors:  K D Cole; C M Tellez; R W Blakesley
Journal:  Electrophoresis       Date:  2000-03       Impact factor: 3.535

2.  Separation of genomic DNA, RNA, and open circular plasmid DNA from supercoiled plasmid DNA by combining denaturation, selective renaturation and aqueous two-phase extraction.

Authors:  Andreas Frerix; Petra Geilenkirchen; Markus Müller; Maria-Regina Kula; Jürgen Hubbuch
Journal:  Biotechnol Bioeng       Date:  2007-01-01       Impact factor: 4.530

3.  High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation.

Authors:  R Lahijani; G Hulley; G Soriano; N A Horn; M Marquet
Journal:  Hum Gene Ther       Date:  1996-10-20       Impact factor: 5.695

4.  Sequences that adopt non-B-DNA conformation in form V DNA as probed by enzymic methylation.

Authors:  S K Brahmachari; Y S Shouche; C R Cantor; M McClelland
Journal:  J Mol Biol       Date:  1987-01-05       Impact factor: 5.469

5.  Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.

Authors:  S E Parker; S Khatibi; M Margalith; D Anderson; M Yankauckas; S H Gromkowski; T Latimer; D Lew; M Marquet; M Manthorpe; P Hobart; E Hersh; A T Stopeck; J Norman
Journal:  Cancer Gene Ther       Date:  1996 May-Jun       Impact factor: 5.987

6.  Mechanisms underlying production of double-strand breaks in plasmid DNA after decay of 125I-Hoechst.

Authors:  Pichumani Balagurumoorthy; Kai Chen; Ralph C Bash; S James Adelstein; Amin I Kassis
Journal:  Radiat Res       Date:  2006-08       Impact factor: 2.841

Review 7.  The promise of nucleic acid vaccines.

Authors:  N P Restifo; H Ying; L Hwang; W W Leitner
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

8.  Auger electron-induced double-strand breaks depend on DNA topology.

Authors:  Pichumani Balagurumoorthy; Kai Chen; S James Adelstein; Amin I Kassis
Journal:  Radiat Res       Date:  2008-07       Impact factor: 2.841

Review 9.  Nonviral gene therapy: the promise of genes as pharmaceutical products.

Authors:  F D Ledley
Journal:  Hum Gene Ther       Date:  1995-09       Impact factor: 5.695

10.  Thiophilic interaction chromatography for supercoiled plasmid DNA purification.

Authors:  Lena M Sandberg; Asa Bjurling; Philippe Busson; Jozsef Vasi; Raf Lemmens
Journal:  J Biotechnol       Date:  2004-04-08       Impact factor: 3.307

  10 in total
  6 in total

1.  Novel method for quantifying radiation-induced single-strand-break yields in plasmid DNA highlights 10-fold discrepancy.

Authors:  Pichumani Balagurumoorthy; S James Adelstein; Amin I Kassis
Journal:  Anal Biochem       Date:  2011-06-24       Impact factor: 3.365

2.  Mitochondrial DNA heteroplasmy in Candida glabrata after mitochondrial transformation.

Authors:  Jingwen Zhou; Liming Liu; Jian Chen
Journal:  Eukaryot Cell       Date:  2010-03-05

3.  Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci.

Authors:  Julia E S Shearer; Joy Wireman; Jessica Hostetler; Heather Forberger; Jon Borman; John Gill; Susan Sanchez; Alexander Mankin; Jacqueline Lamarre; Jodi A Lindsay; Kenneth Bayles; Ainsley Nicholson; Frances O'Brien; Slade O Jensen; Neville Firth; Ronald A Skurray; Anne O Summers
Journal:  G3 (Bethesda)       Date:  2011-12-01       Impact factor: 3.154

4.  A novel process of viral vector barcoding and library preparation enables high-diversity library generation and recombination-free paired-end sequencing.

Authors:  Marcus Davidsson; Paula Diaz-Fernandez; Oliver D Schwich; Marcos Torroba; Gang Wang; Tomas Björklund
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

5.  Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing.

Authors:  Marcus Davidsson; Paula Díaz-Fernández; Marcos Torroba; Oliver D Schwich; Patrick Aldrin-Kirk; Luis Quintino; Andreas Heuer; Gang Wang; Cecilia Lundberg; Tomas Björklund
Journal:  RNA       Date:  2018-01-31       Impact factor: 4.942

6.  Exonuclease combinations reduce noises in 3D genomics technologies.

Authors:  Siyuan Kong; Qing Li; Gaolin Zhang; Qiujia Li; Qitong Huang; Lei Huang; Hui Zhang; Yinghua Huang; Yanling Peng; Baoming Qin; Yubo Zhang
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.